Atopic dermatitis, also known as eczema, is a common skin disorder characterized by flaky skin lesions and intense itching. Eczema affects up to 30% of all children in the US, and the condition can last into adulthood. The cause of eczema is not fully understood. This is a research study for an investigational medication intended to treat eczema.
Eligible participants…
- Are age 12 to 18
- Have moderate to severe eczema
- Have had eczema for at least one year
- May receive compensation for time and travel
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you and your child.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Study Location
Meridian Clinical Research
310 Eisenhower Drive Suite 12A
Savannah, GA 31406
See if You're Eligible...
About Meridian Clinical Research
Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2018 MERIDIAN CLINICAL RESEARCH | Privacy Policy